CDER guidance for generics offers some help to OTC drug makers, but FDA may incorporate guidance in monographs.(Impurities): An article from: Validation Times
Price not available for France
You can still browse on Amazon. Try another country above.
Book Details
Author(s)
Melissa Winn
Publisher
Washington Information Source, Inc.
ISBN / ASIN
B003JK3ZG4
ISBN-13
978B003JK3ZG0
Marketplace
France 🇫🇷
Ratings & Reviews
No reviews yet — be the first!
No reviews yet.
Description
This digital document is an article from Validation Times, published by Washington Information Source, Inc. on October 1, 2009. The length of the article is 950 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available immediately after purchase. You can view it with any web browser.
Citation Details
Title: CDER guidance for generics offers some help to OTC drug makers, but FDA may incorporate guidance in monographs.(Impurities)
Author: Melissa Winn
Publication:Validation Times (Newsletter)
Date: October 1, 2009
Publisher: Washington Information Source, Inc.
Volume: 11 Issue: 10 Page: 1(3)
Distributed by Gale, a part of Cengage Learning
Citation Details
Title: CDER guidance for generics offers some help to OTC drug makers, but FDA may incorporate guidance in monographs.(Impurities)
Author: Melissa Winn
Publication:Validation Times (Newsletter)
Date: October 1, 2009
Publisher: Washington Information Source, Inc.
Volume: 11 Issue: 10 Page: 1(3)
Distributed by Gale, a part of Cengage Learning
